In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells
Start Date
9/1/2017
Completion Date
1/1/2028
Summary
This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach
Detailed Description
Twenty healthy adult study participants between the ages of 18 and 60 years will be recruited to participate in this pilot study that will include two groups: a) Ex Vivo group (10 volunteers) and b) In Vivo group (10 volunteers). Volunteers will be recruited to either group in a sequential alternating fashion. In vivo 13C SIRM studies evaluating the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells.
Eligibility Criteria
Age Range: 18 years to 60 years
Interventions
5-13C-Glutamine
Bone marrow aspiration
Conditions
Locations
Mayo Clinic
Rochester, Minnesota 55905
United States